Carnosol Modulates Th17 Cell Differentiation and Microglial Switch in Experimental Autoimmune Encephalomyelitis

Area of Science:

• Phytochemistry
• Immunology
• Neuroscience

Background:

• Medicinal plants have historically provided therapeutics for autoimmune diseases.
• Carnosol, a diterpene from rosemary and sage, is explored for its therapeutic potential.
• Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.

Purpose of the Study:

• To investigate the therapeutic effects of carnosol in experimental autoimmune encephalomyelitis (EAE), a model for MS.
• To elucidate the molecular mechanisms underlying carnosol's action in EAE.
• To evaluate carnosol's efficacy in both acute and chronic EAE stages.

Main Methods:

• Induction of EAE using myelin oligodendrocyte glycoprotein (MOG35-55) peptide.
• Administration of carnosol during the development and chronic stages of EAE.
• Assessment of clinical symptoms, inflammatory cell infiltration, demyelination, and immune cell phenotypes (Th17, macrophage/microglia).
• Analysis of molecular pathways including STAT3 phosphorylation and NF-κB translocation.

Main Results:

• Carnosol treatment significantly reduced EAE clinical scores, inflammatory infiltration, and demyelination.
• Carnosol inhibited Th17 cell differentiation and STAT3 phosphorylation.
• The compound blocked NF-κB nuclear translocation and modulated macrophage/microglia phenotypes in chronic EAE.

Conclusions:

• Carnosol demonstrates significant therapeutic potential for autoimmune diseases, particularly MS.
• Its mechanism involves suppressing inflammatory immune responses and modulating CNS-resident immune cells.
• Carnosol warrants further investigation as a novel therapeutic agent for MS and related autoimmune conditions.